Skip to main content Back to Top
Advertisement

5/26/2016

Atorvastatin Tablets

Products Affected - Description

    • Atorvastatin tablet, Apotex, 10 mg, 90 count, NDC 60505-2578-09
    • Atorvastatin tablet, Apotex, 10 mg, 1000 count, NDC 60505-2578-08
    • Atorvastatin tablet, Apotex, 20 mg, 90 count, NDC 60505-2579-09
    • Atorvastatin tablet, Apotex, 20 mg, 1000 count, NDC 60505-2579-08
    • Atorvastatin tablet, Apotex, 40 mg, 90 count, NDC 60505-2580-09
    • Atorvastatin tablet, Apotex, 40 mg, 1000 count, NDC 60505-2580-08
    • Atorvastatin tablet, Apotex, 80 mg, 90 count, NDC 60505-2671-09
    • Atorvastatin tablet, Apotex, 80 mg, 1000 count, NDC 60505-2671-08
    • Atorvastatin tablet, Sandoz, 40 mg, 90 count, NDC 00781-5384-92

Reason for the Shortage

    • Ranbaxy discontinued atorvastatin in late-2014.
    • Apotex has atorvastatin tablets on allocation due to increased demand.
    • Sandoz states the shortage is due to demand exceeding supply.

Available Products

    • Lipitor tablet, Pfizer, 10 mg, 90 count, NDC 00071-0155-23
    • Lipitor tablet, Pfizer, 10 mg, 100 count, NDC 00071-0155-40
    • Lipitor tablet, Pfizer, 10 mg, 5000 count, NDC 00071-0155-34
    • Lipitor tablet, Pfizer, 20 mg, 90 count, NDC 00071-0156-23
    • Lipitor tablet, Pfizer, 20 mg, 100 count, NDC 00071-0156-40
    • Lipitor tablet, Pfizer, 20 mg, 5000 count, NDC 00071-0156-94
    • Lipitor tablet, Pfizer, 40 mg, 90 count, NDC 00071-0157-23
    • Lipitor tablet, Pfizer, 40 mg, 100 count, NDC 00071-0157-40
    • Lipitor tablet, Pfizer, 40 mg, 500 count, NDC 00071-0157-73
    • Lipitor tablet, Pfizer, 40 mg, 2500 count, NDC 00071-0157-88
    • Lipitor tablet, Pfizer, 80 mg, 64 count, NDC 00071-0158-92
    • Lipitor tablet, Pfizer, 80 mg, 90 count, NDC 00071-0158-23
    • Lipitor tablet, Pfizer, 80 mg, 500 count, NDC 00071-0158-73
    • Lipitor tablet, Pfizer, 80 mg, 2500 count, NDC 00071-0158-88
    • Atorvastatin tablet, Dr. Reddy's, 10 mg, 90 count, NDC 55111-0121-90
    • Atorvastatin tablet, Dr. Reddy's, 10 mg, 500 count, NDC 55111-0121-05
    • Atorvastatin tablet, Dr. Reddy's, 20 mg, 90 count, NDC 55111-0122-90
    • Atorvastatin tablet, Dr. Reddy's, 20 mg, 500 count, NDC 55111-0122-05
    • Atorvastatin tablet, Dr. Reddy's, 40 mg, 90 count, NDC 55111-0123-90
    • Atorvastatin tablet, Dr. Reddy's, 40 mg, 500 count, NDC 55111-0123-05
    • Atorvastatin tablet, Dr. Reddy's, 80 mg, 90 count, NDC 55111-0124-90
    • Atorvastatin tablet, Dr. Reddy's, 80 mg, 500 count, NDC 55111-0124-05
    • Atorvastatin tablet, Greenstone, 10 mg, 90 count, NDC 59762-0155-01
    • Atorvastatin tablet, Greenstone, 10 mg, 1000 count, NDC 59762-0155-02
    • Atorvastatin tablet, Greenstone, 20 mg, 90 count, NDC 59762-0156-01
    • Atorvastatin tablet, Greenstone, 20 mg, 1000 count, NDC 59762-0156-02
    • Atorvastatin tablet, Greenstone, 40 mg, 500 count, NDC 59762-0157-02
    • Atorvastatin tablet, Greenstone, 80 mg, 90 count, NDC 59762-0158-01
    • Atorvastatin tablet, Greenstone, 80 mg, 500 count, NDC 59762-0158-02
    • Atorvastatin tablet, Kremers Urban, 10 mg, 90 count, NDC 62175-0890-46
    • Atorvastatin tablet, Kremers Urban, 10 mg, 1000 count, NDC 62175-0890-43
    • Atorvastatin tablet, Kremers Urban, 20 mg, 90 count, NDC 62175-0891-46
    • Atorvastatin tablet, Kremers Urban, 20 mg, 1000 count, NDC 62175-0891-43
    • Atorvastatin tablet, Kremers Urban, 40 mg, 90 count, NDC 62175-0892-41
    • Atorvastatin tablet, Kremers Urban, 40 mg, 500 count, NDC 62175-0892-46
    • Atorvastatin tablet, Kremers Urban, 80 mg, 90 count, NDC 62175-0897-46
    • Atorvastatin tablet, Kremers Urban, 80 mg, 500 count, NDC 62175-0897-41
    • Atorvastatin tablet, Major, 10 mg, 100 count, NDC 00904-6290-61
    • Atorvastatin tablet, Major, 20 mg, 100 count, NDC 00904-6291-61
    • Atorvastatin tablet, Mylan, 10 mg, 90 count, NDC 00378-3950-77
    • Atorvastatin tablet, Mylan, 10 mg, 500 count, NDC 00378-3950-05
    • Atorvastatin tablet, Mylan, 20 mg, 90 count, NDC 00378-3951-77
    • Atorvastatin tablet, Mylan, 20 mg, 500 count, NDC 00378-3951-05
    • Atorvastatin tablet, Mylan, 40 mg, 90 count, NDC 00378-3952-77
    • Atorvastatin tablet, Mylan, 40 mg, 500 count, NDC 00378-3952-05
    • Atorvastatin tablet, Mylan, 80 mg, 90 count, NDC 00378-3953-77
    • Atorvastatin tablet, Mylan, 80 mg, 500 count, NDC 00378-3953-05
    • Atorvastatin tablet, Mylan Institutional, 10 mg, 100 count, NDC 51079-0208-20
    • Atorvastatin tablet, Mylan Institutional, 20 mg, 100 count, NDC 51079-0209-20
    • Atorvastatin tablet, Mylan Institutional, 40 mg, 100 count, NDC 51079-0210-20
    • Atorvastatin tablet, Mylan Institutional, 80 mg, 30 count, NDC 51079-0211-03
    • Atorvastatin tablet, Sandoz, 10 mg, 90 count, NDC 00781-5381-92
    • Atorvastatin tablet, Sandoz, 20 mg, 90 count, NDC 00781-5382-92
    • Atorvastatin tablet, Sandoz, 80 mg, 90 count, NDC 00781-5388-92

Estimated Resupply Dates

    • Apotex has atorvastatin tablets available to contracted customers and based on customer's forecast.
    • Sandoz has atorvastatin 40 mg tablets on back order and the company cannot estimate a release date.

Updated

Updated May 26, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 18, 2013 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins